Cisen Pharmaceutical Co Ltd Strategic Asset Allocation Index
Cisen Pharmaceutical Co Ltd strategic asset allocation index. Cisen Pharmaceutical Co Ltd (603367) has a Strategic Asset Allocation Index of 25.5% as of June 2023. Strategic assets (PP&E of CN¥1.39 Billion plus long-term investments of CN¥-) total CN¥1.39 Billion, measured against net assets of CN¥5.48 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Cisen Pharmaceutical Co Ltd balance sheet quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Cisen Pharmaceutical Co Ltd (2011–2022)
Strategic asset allocation index of Cisen Pharmaceutical Co Ltd from 2011 to 2022. This chart shows how Cisen Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 12 annual periods from 2011 to 2022. As of June 2023, the index stands at 25.5%, representing strategic assets of CN¥1.39 Billion against net assets of CN¥5.48 Billion CNY. Check 603367 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Cisen Pharmaceutical Co Ltd Strategic Asset Allocation Index by Year (2011–2022)
Cisen Pharmaceutical Co Ltd strategic asset allocation index by year from 2011 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Cisen Pharmaceutical Co Ltd from 2011 to 2022, covering 12 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 603367 company net worth.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 27.8% | CN¥1.49 Billion | CN¥1.49 Billion | CN¥- | CN¥5.36 Billion | ▼ -3.7 pp |
| 2021 | 31.5% | CN¥1.59 Billion | CN¥1.59 Billion | CN¥- | CN¥5.06 Billion | ▼ -2.6 pp |
| 2020 | 34.1% | CN¥1.64 Billion | CN¥1.64 Billion | CN¥- | CN¥4.80 Billion | ▲ +4.7 pp |
| 2019 | 29.4% | CN¥1.34 Billion | CN¥1.34 Billion | CN¥- | CN¥4.57 Billion | ▼ -1.6 pp |
| 2018 | 31.0% | CN¥1.29 Billion | CN¥1.29 Billion | CN¥- | CN¥4.15 Billion | ▼ -4.1 pp |
| 2017 | 35.0% | CN¥1.31 Billion | CN¥1.31 Billion | CN¥- | CN¥3.72 Billion | ▼ -28.0 pp |
| 2016 | 63.1% | CN¥1.45 Billion | CN¥1.45 Billion | CN¥- | CN¥2.30 Billion | ▼ -9.0 pp |
| 2015 | 72.1% | CN¥1.51 Billion | CN¥1.51 Billion | CN¥- | CN¥2.10 Billion | ▼ -8.4 pp |
| 2014 | 80.5% | CN¥1.53 Billion | CN¥1.53 Billion | CN¥- | CN¥1.90 Billion | ▲ +10.1 pp |
| 2013 | 70.4% | CN¥1.22 Billion | CN¥1.22 Billion | CN¥- | CN¥1.73 Billion | ▲ +17.1 pp |
| 2012 | 53.3% | CN¥845.08 Million | CN¥845.08 Million | CN¥- | CN¥1.58 Billion | ▲ +5.1 pp |
| 2011 | 48.2% | CN¥647.80 Million | CN¥647.80 Million | CN¥- | CN¥1.34 Billion | — |